| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.79 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,922,851 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,660,378 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
29 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Seeley Bruce J. |
EVP, Chief Commercial Officer |
• – – |
2016-12-31 |
4 |
A |
$0.30 |
$1,523 |
D/D |
5,000 |
310,000 |
|
- |
|
| Seeley Bruce J. |
EVP, Chief Commercial Officer |
• – – |
2016-06-30 |
4 |
A |
$0.29 |
$1,445 |
D/D |
5,000 |
305,000 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-06-24 |
4 |
AS |
$0.37 |
$3,654 |
D/D |
(10,000) |
1,780,133 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-05-27 |
4 |
AS |
$0.45 |
$4,471 |
D/D |
(10,000) |
1,790,133 |
|
- |
|
| Mundinger Mary Oneil |
Director |
– • – |
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
360,019 |
|
- |
|
| Love Richard L |
Director |
– • – |
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
535,824 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-04-29 |
4 |
AS |
$0.52 |
$5,162 |
D/D |
(10,000) |
1,800,133 |
|
- |
|
| Tuckson Reed Vaughn |
Director |
– • – |
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
576,881 |
|
- |
|
| Telling Fred |
Director |
– • – |
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
441,389 |
|
- |
|
| Nudelman Phillip M Phd |
Director |
– • – |
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
79,618 |
334,311 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-03-28 |
4 |
AS |
$0.49 |
$4,941 |
D/D |
(10,000) |
1,810,133 |
|
- |
|
| Plunkett Matthew |
EVP, Chief Business Officer |
• – – |
2016-03-21 |
4 |
D |
$0.55 |
$35,016 |
D/D |
(63,874) |
526,210 |
|
- |
|
| Bianco Louis A |
EVP, Finance & Administration |
• – – |
2016-03-21 |
4 |
D |
$0.55 |
$25,522 |
D/D |
(46,556) |
622,933 |
|
- |
|
| Singer Jack W |
EVP, Chief Scientific Officer |
• • – |
2016-03-21 |
4 |
D |
$0.55 |
$25,182 |
D/D |
(45,935) |
994,057 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-03-21 |
4 |
AS |
$0.55 |
$174,866 |
D/D |
(318,169) |
1,820,133 |
|
- |
|
| Plunkett Matthew |
EVP, Chief Business Officer |
• – – |
2016-03-04 |
4 |
AS |
$0.59 |
$5,904 |
D/D |
(10,000) |
590,084 |
|
- |
|
| Singer Jack W |
EVP, Chief Scientific Officer |
• • – |
2016-02-26 |
4 |
AS |
$0.62 |
$9,517 |
D/D |
(15,000) |
1,039,992 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-02-26 |
4 |
AS |
$0.63 |
$6,294 |
D/D |
(10,000) |
2,138,302 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-02-16 |
4 |
AS |
$0.42 |
$41,920 |
D/D |
(100,000) |
2,148,302 |
|
- |
|
| Plunkett Matthew |
EVP, Chief Business Officer |
• – – |
2016-02-04 |
4 |
AS |
$1.14 |
$11,539 |
D/D |
(10,000) |
600,084 |
|
- |
|
| Bianco James A |
President and CEO |
• • – |
2016-01-29 |
4 |
AS |
$1.20 |
$12,012 |
D/D |
(10,000) |
2,248,302 |
|
- |
|
| Singer Jack W |
EVP, Chief Scientific Officer |
• • – |
2016-01-29 |
4 |
AS |
$1.17 |
$17,730 |
D/D |
(15,000) |
1,054,992 |
|
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2016-01-08 |
4 |
B |
$1.22 |
$71,338 |
I/I |
58,613 |
17,263,200 |
1.5 |
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2016-01-08 |
4 |
B |
$1.22 |
$376,004 |
D/D |
308,934 |
3,090,744 |
2.45 |
- |
|
| Lampert Mark N |
10% Owner |
– – • |
2016-01-07 |
4 |
B |
$1.22 |
$9,848 |
I/I |
8,091 |
17,204,587 |
1.5 |
- |
|
229 Records found
|
|
Page 5 of 10 |
|
|
